Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy

p53 Counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition

(2012) R Brosh et al.   CELL DEATH AND DIFFERENTIATION

The flick of a switch: which death program to choose?

(2012) P Vandenabeele et al.   CELL DEATH AND DIFFERENTIATION

p73 is dispensable for commitment to neural stem cell fate, but is essential for neural stem cell maintenance and for blocking premature differentiation

(2012) E M Alexandrova et al.   CELL DEATH AND DIFFERENTIATION

The 5th International p63/p73 workshop: much more than just tumour suppression

(2012) M P Kadakia et al.   CELL DEATH AND DIFFERENTIATION

TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses

(2012) R Tomasini et al.   CELL DEATH AND DIFFERENTIATION

Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis

(2012) F Nikulenkov et al.   CELL DEATH AND DIFFERENTIATION

Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer

(2012) P. Tucci et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structural Basis for the Versatile Interactions of Smad7 with Regulator WW Domains in TGF-β Pathways

(2012) Eric Aragón et al.   STRUCTURE

PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage

(2012) B H Huang et al.   Cell Death & Disease

TP53 PIN3 and PEX4 polymorphisms and infertility associated with endometriosis or with post-in vitro fertilization implantation failure

(2012) D D Paskulin et al.   Cell Death & Disease

Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes

(2012) I Masse et al.   Cell Death & Disease

Gamma-ray irradiation promotes premature meiosis of spontaneously differentiating testis–ova in the testis of p53-deficient medaka (Oryzias latipes)

(2012) T Yasuda et al.   Cell Death & Disease

Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition

(2012) D Dixit et al.   Cell Death & Disease

MicroRNA-203 contributes to skin re-epithelialization

(2012) G Viticchiè et al.   Cell Death & Disease

Regulation of p73 activity by post-translational modifications

(2012) F Conforti et al.   Cell Death & Disease

MicroRNA-203 inhibits cell proliferation by repressing ΔNp63 expression in human esophageal squamous cell carcinoma

(2011) Yang Yuan et al.   BMC CANCER

 Np63  Confers Tumor Cell Resistance to Cisplatin through the AKT1 Transcriptional Regulation

(2011) T. Sen et al.   CANCER RESEARCH

 Np63 Versatilely Regulates a Broad NF- B Gene Program and Promotes Squamous Epithelial Proliferation, Migration, and Inflammation

(2011) X. Yang et al.   CANCER RESEARCH

Mutant p53 protein, master regulator of human malignancies: a report on the fifth Mutant p53 Workshop

(2011) G Blandino et al.   CELL DEATH AND DIFFERENTIATION

Regulation of skin aging and heart development by TAp63

(2011) M Paris et al.   CELL DEATH AND DIFFERENTIATION

Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells

(2011) Y Huang et al.   CELL DEATH AND DIFFERENTIATION

Biological functions of p53 isoforms through evolution: lessons from animal and cellular models

(2011) V Marcel et al.   CELL DEATH AND DIFFERENTIATION

Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity

(2011) V Marcel et al.   CELL DEATH AND DIFFERENTIATION

WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β

(2011) H-Y Wang et al.   CELL DEATH AND DIFFERENTIATION

p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53

(2011) G Melino   CELL DEATH AND DIFFERENTIATION

Wwox inactivation enhances mammary tumorigenesis

(2011) S K Abdeen et al.   ONCOGENE

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

(2011) M Michaelis et al.   Cell Death & Disease

Effect of doxycycline on proliferation, MMP production, and adhesion in LAM-related cells

(2010) William Y. C. Chang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway

(2010) Zhijian Du et al.   CANCER SCIENCE

WWOXgene and gene product: tumor suppression through specific protein interactions

(2010) Zaidoun Salah et al.   Future Oncology

TAp63α Mediates Chemotherapeutic Agent-Induced Apoptosis in Human Bone Marrow Mesenchymal Stem Cells

(2010) Chunhua Lu et al.   STEM CELLS AND DEVELOPMENT

c-Abl phosphorylation of ΔNp63α is critical for cell viability

(2010) M Yuan et al.   Cell Death & Disease

Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells

(2009) Faryar Foroodi et al.   ANTI-CANCER DRUGS

A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis

(2009) Maddalena Adorno et al.   CELL

WWOX: Its genomics, partners, and functions

(2009) Sara Del Mare et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells

(2009) Q Sun et al.   ONCOGENE

The WWOX Tumor Suppressor Is Essential for Postnatal Survival and Normal Bone Metabolism

(2008) Rami I. Aqeilan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY